Immunovant (IMVT) Common Equity (2018 - 2026)
Immunovant (IMVT) recorded Common Equity of $735.39 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 20.8% from $608.54 million a year earlier but down 13.7% from the prior quarter.
Powered by 
Analysis
Immunovant (IMVT) Common Equity (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Immunovant reported Common Equity of $852.59 million, up 20.5% from FY2025.
- Annual Common Equity has increased for three straight fiscal years, with a five-year compound annual growth rate of 16.8% (FY2021 to FY2026).
- Across earlier fiscal years, Common Equity came in at $707.45 million in FY2025 (+14.5%), $617.76 million in FY2024 (+70.4%), $362.49 million in FY2023 (-22.8%) and $469.83 million in FY2022 (+20.0%).
- Quarterly Common Equity has ranged from $251.81 million in fiscal Q2 2024 to $986.14 million in fiscal Q3 2026 over the past five years.
- On a year-over-year basis, Common Equity has increased for six consecutive quarters, with growth averaging 36.7% over the last eight quarters.
- Peak year-over-year performance for Common Equity in the last five years was growth of 179.7% in fiscal Q3 2026, against a decline of 48.1% in fiscal Q3 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $852.59 million (Q4 2026), $986.14 million (Q3 2026) and $519.71 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Immunovant | 6.91 Bn | 6.91 Bn | - | 735.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 735.39 Mn |
| Mar 31, 2026 | 852.59 Mn |
| Dec 31, 2025 | 986.14 Mn |
| Sep 30, 2025 | 519.71 Mn |
| Jun 30, 2025 | 608.54 Mn |
| Mar 31, 2025 | 707.45 Mn |
| Dec 31, 2024 | 352.62 Mn |
| Sep 30, 2024 | 449.05 Mn |
| Jun 30, 2024 | 544.66 Mn |
| Mar 31, 2024 | 617.76 Mn |
| Dec 31, 2023 | 679.34 Mn |
| Sep 30, 2023 | 251.81 Mn |
| Jun 30, 2023 | 299.87 Mn |
| Mar 31, 2023 | 362.49 Mn |
| Dec 31, 2022 | 414.68 Mn |
| Sep 30, 2022 | 395.75 Mn |
| Jun 30, 2022 | 436.49 Mn |
| Mar 31, 2022 | 469.83 Mn |
| Dec 31, 2021 | 505.15 Mn |
| Sep 30, 2021 | 536.40 Mn |
API Access
Immunovant Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();